The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of clinical benefit and progression-free survival ratio of targeted treatments in a prospective cohort study of patients with biliary tract cancers.
 
Monica Niger
Honoraria - Basilea Pharmaceutical; EMD Serono; Incyte; MSD; National Academy of Medicine
Travel, Accommodations, Expenses - Celgene
 
Federico Nichetti
No Relationships to Disclose
 
Andrea Vingiani
No Relationships to Disclose
 
Chiara Carlotta Pircher
No Relationships to Disclose
 
Luca Agnelli
No Relationships to Disclose
 
Elena Conca
No Relationships to Disclose
 
Elena Tamborini
No Relationships to Disclose
 
Federica Perrone
No Relationships to Disclose
 
Eleonora Gusmaroli
No Relationships to Disclose
 
Andrea Franza
No Relationships to Disclose
 
Francesca Corti
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen
 
Leonardo Provenzano
No Relationships to Disclose
 
Federica Morano
Honoraria - Lilly; SERVIER
Travel, Accommodations, Expenses - Sanofi; SERVIER
 
Giancarlo Pruneri
Honoraria - Genomic Health; Novartis; Roche
Consulting or Advisory Role - ADS Biotec; ADS Biotec
Research Funding - Roche; Roche Molecular Diagnostics
 
Maria Di Bartolomeo
Honoraria - BMSi; Lilly; MSD Oncology; SERVIER
Consulting or Advisory Role - Lilly; MSD Oncology
Research Funding - Lilly (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Filippo Pietrantonio
Honoraria - Amgen; AstraZeneca/MedImmune; Bayer; Lilly; MSD Oncology; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; SERVIER
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Filippo G. De Braud
Honoraria - Amgen Astellas BioPharma; BMS; Incyte; Merck; MSD; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD SERONO; Incyte; Menarini; Nerviano Medical Sciences; Nerviano Medical Sciences; Novartis Italy; Pierre Fabre; Roche; Sanofi
Research Funding - Basilea Pharmaceutical; Bayer Health; Bristol-Myers Squibb/Medarex; Daiichi Sankyo Europe GmbH; Exelixis; Ignyta; incyte; Janssen Oncology; Kymab (Inst); Loxo (Inst); MedImmune; Merck KGaA; Merck Serono (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Roche (Inst); SERVIER (Inst); Tesaro (Inst)